TMP-SMX for pneumonia in non-HIV patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether the antibiotic TMP-SMX is safe and effective for treating a type of pneumonia (PCP) in people who do not have HIV. It aims to find better treatment options for this serious lung infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of PCP (a lung infection) that is not linked to HIV.
- You must be starting treatment for PCP with the antibiotic TMP-SMX.
- You must agree to take part in the study by signing a consent form.
- You cannot be pregnant or breastfeeding.
- You must not have had a severe allergic reaction to TMP-SMX in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.
This study tests whether treating a specific germ (Pneumocystis jirovecii) in the lungs can reduce the number of COPD flare-ups. If you have COPD with frequent flare-ups and this germ is found in your sputum, you may benefit.
This trial tests different antibiotics for people with pneumocystis pneumonia who cannot take the standard treatment. It aims to find the best alternative therapy.
This study compares two different doses of an antibiotic (TMP-SMX) to prevent a serious lung infection called Pneumocystis pneumonia that can occur after kidney transplant. The goal is to find the safest, most effective dose for transplant patients.
This trial tests how long kidney transplant patients should take a common antibiotic (sulfamethoxazole) to prevent a lung infection called PJP. You may join if you are between 18 and 70 and have had a kidney transplant.
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
Hear when a new Pneumocystis Jirovecii Pneumonia in Non-HIV Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.